ulmonary vein isolation (PVI) is an effective technique for curing atrial fibrillation (AF), [1][2][3][4][5][6][7][8] and it has been reported that adding an ablation to the PV ablation that is aimed at vagal denervation adequate for eliminating vagal reflexes 9 or targeting the ganglionated plexi in the left atrium (LA) 10 may reduce AF recurrence. Those reports suggest that modification of the autonomic nervous function may prevent AF recurrence after PVI. PVI alone has been proved to induce an immediate decrease in autonomic nervous function, 11,12 but the relationship between modification of the autonomic nervous function and AF recurrence after PVI remains unclear, because multiple factors may be associated with AF recurrence. This study was undertaken to investigate whether or not vagal denervation is an independent predictor of AF recurrence after PVI.
Methods
Study PopulationThe study population consisted of 120 consecutive patients (93 men, 59±11 years; range 29-80 years) with symptomatic paroxysmal AF (PAF) refractory to 3±1 class I or III antiarrhythmic drugs (not including amiodarone). The mean PAF history was 4±4 years (0-17). The mean echocardiographic dimension of the LA was 35±6 mm (25-46) and mean left ventricular ejection fraction was 67±9% (50-89). The exclusion criteria were sick sinus syndrome, diabetes mellitus, thyroid dysfunction, recent myocardial infarction (<6 months), history of a prior thoracotomy, β-blocker therapy, and a pacing rhythm. The first 60 patients underwent segmental PVI (S-PVI) and the second 60 patients underwent circumferential PVI (C-PVI). These patients were retrospectively examined. Each patient gave written informed consent, and all antiarrhythmic drugs were discontinued for at least 5 half-lives prior to the study.
Electrophysiologic StudyA 7-French decapolar catheter with 1-5-1-mm interelectrode spacing between each electrode pair (St Jude Medical, AF Division, Minnetonka, MN, USA) was deployed into the coronary sinus via the subclavian vein. The transseptal (Received March 10, 2009; accepted April 27, 2009